Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement

Dermatology. 2010;220(3):282-6. doi: 10.1159/000277928. Epub 2010 Jan 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Arthritis / drug therapy*
  • Arthritis / pathology
  • Aspirin / therapeutic use
  • Azathioprine / therapeutic use
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / pathology
  • Chronic Disease
  • Colchicine / therapeutic use
  • HLA-B Antigens / analysis
  • HLA-B51 Antigen
  • Humans
  • Ileitis / drug therapy*
  • Ileitis / pathology
  • Infliximab
  • Magnetic Resonance Imaging
  • Male
  • Prednisone / therapeutic use
  • Retinal Vasculitis / drug therapy*
  • Retinal Vasculitis / pathology
  • Scrotum / pathology
  • Vasculitis, Central Nervous System / drug therapy*

Substances

  • Antibodies, Monoclonal
  • HLA-B Antigens
  • HLA-B51 Antigen
  • Infliximab
  • Azathioprine
  • Aspirin
  • Colchicine
  • Prednisone